This webinar brings together three leading voices from Japan’s academic and industrial sectors to explore the evolving landscape of CAR-T cell therapy. Prof. Keichiro Mihara of Fujita Health University will present his insights on the progress and challenges of off-the-shelf CAR-T therapies, emphasizing scalable and accessible treatment models. Prof. Koji Tamada, MD, PhD, of Yamaguchi University will share cutting-edge research on immune-regulatory CAR-T cells targeting intractable solid tumors, offering a glimpse into the future of personalized immunotherapy. Dr. Yasushi Tanaka, President of Teijin Regenet (TRG), will introduce the company’s strategic initiatives to commercialize and deliver advanced cell therapies, highlighting Japan’s role in translating innovation into clinical solutions. This session is designed for professionals in cell and gene therapy, oncology, and regenerative medicine, providing a unique opportunity to learn from Japan’s integrated approach to innovation, collaboration, and global outreach.